September 2009
Synthesis of Functionalized 1,2,3-Triazole Derivatives of 2-Indolones from
Morita-Baylis-Hillman Adducts of Isatin via ‘‘Click Chemistry’’
923
(t, J ¼ 3.24 Hz, 3H), 2.03 (brs, 1H,), 3.95 (q, J ¼ 4.5, 11.8
Hz, 2H), 4.92 (d, J ¼ 15.8 Hz, 1H), 5.09 (d, J ¼ 15.9 Hz,
1H), 5.45 (AB quartet, J ¼ 11.9 Hz, 2H), 6.48 (s, 1H), 6.60
(s, 1H), 6.79–7.01 (m, 3H), 7.26–7.38 (m, 5H), 7.60 (s, 1H).
MS (EI) m/z 266 (Mþ);13C NMR (CDCl3/TMS, 125 MHz):
13.8, 14.1, 22.6, 22.9, 29.6, 34.6, 52.7, 54.3, 61.1, 75.7, 111.4,
115.7, 122.8, 125.0, 127.0, 128.1, 128.2, 128.7, 129.0, 135.2,
138.4, 142.0, 164.3, 175.4. MS (EI) m/z 497 (Mþ), 499
(M þ 2).
1H), 6.35–6.98 (m, 9H), 7.38 (s, 1H); 13C NMR (CDCl3/TMS,
75.3 MHz): 30.1, 52.3, 53.9, 68.1, 74.2, 112.2, 114.9, 116.3,
125.9, 127.6, 128.1, 128.5, 129.4, 133.0, 135.5, 138.3, 138.6,
164.7, 177.1. MS (EI) m/z 402 (Mþ).
2-(1-(((1-benzyl-1H-1,2,3-triazol-4-yl)methoxy) methyl)-5-
fluoro-3-hydroxy-2-oxoindolin-3-yl)acrylonitrile (6b). White
solid: Rf (60% EA/hexane) 0.29; IR (KBr): 3382, 1621, 1486,
1112 cmꢂ1 1H NMR (CDCl3/TMS, 300.1 MHz): d 4.63 (d,
;
J ¼ 13.2 Hz, 1H), 4.72 (d, J ¼ 13.1 Hz, 1H), 5.06 (d, J ¼ 11.4
Hz, 1H), 5.36 (AB quartet, J ¼ 9.8 Hz, 2H), 5.53 (d, J ¼ 11.4
Hz, 1H), 5.84 (brs, 1H), 6.25 (s, 1H), 6.58 (s, 1H), 6.78–6.81 (m,
4H), 7.00–7.12 (m, 4H), 7.35 (s, 1H); 13C NMR (CDCl3/TMS,
75.3 MHz): 35.7, 53.2, 53.9, 69.7, 76.1, 111.5, 113.4, 115.8,
116.1, 123.3, 128.6, 128.1, 128.7, 128.9, 132.4, 134.7, 137.9,
138.3, 144.0, 164.4, 175.6. MS (EI) m/z 420 (Mþ).
Butyl 2-(1-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-5-bromo-
3-hydroxy-2-oxoindolin-3-yl)acrylate (4h). White solid: Rf
(60% EA/hexane) 0.25; IR (KBr): 3383, 1718, 1612, 1490,
1
1327, 1171 cmꢂ1; H NMR (CDCl3/TMS, 300.1 MHz): d 0.88
(t, J ¼ 7.2 Hz, 3H), 1.19–1.29 (m, 4H), 3.89 (t, J ¼ 6.9 Hz,
2H), 4.08 (brs, 1H), 4.91 (d, J ¼ 15.6 Hz, 1H), 5.08 (d, J ¼
15.9 Hz, 1H), 5.44 (AB quartet, J ¼ 12.1 Hz, 2H), 6.47 (s,
1H), 6.61 (s, 1H), 6.84 (d, 1H, J ¼ 8.1 Hz), 7.24–7.38 (m,
7H), 7.61 (s, 1H). MS (EI) m/z 266 (Mþ);13C NMR (CDCl3/
TMS, 125 MHz): 13.6, 18.9, 19.0, 29.6, 30.2, 36.0, 43.3, 54.3,
64.9, 75.7, 111.4, 115.7, 122.8, 127.0, 128.1, 128.2, 128.6,
128.7 (C), 129.0, 129.3, 132.6, 134.3, 138.4, 142.0, 164.4,
175.5. MS (EI) m/z 525 (Mþ), 527 (M þ 2).
Methyl2-(1-(((1-benzyl-1H-1,2,3-triazol-4-yl)methoxy) methyl)-
5-fluoro-3-hydroxy-2-oxoindolin-3-yl) acrylate (6c). White solid:
Rf (60% EA/hexane) 0.29; IR (KBr): 3386, 1722, 1617, 1483,
1110 cmꢂ1 1H NMR (CDCl3/TMS, 300.1 MHz): d 3.50 (s,
;
3H), 4.60 (d, J ¼ 12.6 Hz, 1H), 4.68 (d, J ¼ 12.8 Hz, 1H),
5.11 (d, J ¼ 11.2 Hz, 1H), 5.29 (d, J ¼ 11.3 Hz, 1H), 5.40–
5.51 (m, 2H), 5.71 (s, 1H, br), 6.61 (s, 1H), 6.83 (s, 1H),
6.83–6.93 (m, 3H), 7.30–7.36 (m, 3H), 7.14–7.17 (s, 2H), 7.42
(s, 1H); 13C NMR (CDCl3/TMS, 75.3 MHz): 14.8, 35.9, 51.8,
53.9, 69.7, 75.8, 110.5, 111.7, 115.8, 116.1, 123.3, 127.9,
128.4, 128.6, 128.9, 131.4, 134.2, 138.1, 138.3, 144.0, 164.8,
176.9. MS (EI) m/z 453 (Mþ).
2-(1-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-5-fluoro 3-
hydroxy-2-oxoindolin-3-yl)acrylonitrile (4i). White solid: Rf
(60% EtOAc/hexane) 0.32; IR (KBr): 3386, 2243, 1726, 1619,
1
1490, 1343, 1171 cmꢂ1; H NMR (CDCl3/TMS, 300.1 MHz):
d 2.02 (brs, 1H), 4.89 (d, J ¼ 15.8 Hz, 1H), 4.99 (d, J ¼ 15.8
Hz, 1H), 5.40 (d AB quartet, J ¼ 13.3 Hz, 2H), 6.17 (s, 1H),
6.43 (s, 1H), 6.96–7.09 (m, 3H), 7.22 (d, J ¼ 3.3 Hz, 1H),
7.26–7.34 (m, 4H), 7.51 (s, 1H); 13C NMR (CDCl3/TMS, 75.3
MHz): 35.8, 52.0, 54.2, 76.5, 109.2, 112.4, 115.5, 122.1 122.7,
123.5, 128.0, 128.7, 129.0, 131.9, 134.0, 140.1, 141.8, 142.5,
143.3, 173.8. MS (EI) m/z 390 (Mþ).
Acknowledgments. M. D. and K. S. thanks UGC and CSIR
(New Delhi) for the award of a Senior Research Fellowships. Fi-
nancial support (SR/S1/OC-38/2005) from the DST (New Delhi)
is gratefully acknowledged. Thanks to Mrs. Viji and Mrs. Sou-
mini Mathew for providing mass and NMR data, respectively.
Methyl 2-(1-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-5-flu-
oro-3-hydroxy-2-oxoindolin-3-yl)acrylate (4j). White solid: Rf
(60% EtOAc/hexane) 0.28; IR (KBr): 3362, 2217, 1722, 1612,
REFERENCES AND NOTES
1
1490, 1334 cmꢂ1; H NMR (CDCl3/TMS, 300.1 MHz): d 3.50
[1] (a) Alvarez, R.; Velazquez, S.; San, F.; Aquaro, S.; De, C.;
Perno, C. F.; Karlsson, A.; Balzarini, J.; Camarasa, M. J. J Med Chem
1994, 37, 4185; (b) Velazquez, S.; Alvarez, R.; Perez, C.; Gago, F.; De,
C.; Balzarini, J.; Camarasa, M. J. Antivir Chem Chemother 1998, 9, 481.
[2] Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew Chem
Int Ed Engl 2001, 40, 2004.
(s, 3H), 4.65 (brs, 1H), 4.86 (d, J ¼ 15.9 Hz, 1H), 5.08 (d, J
¼ 15.9 Hz, 1H), 5.41 (AB quartet, J ¼ 10.0 Hz, 2H), 6.46 (s,
1H), 6.51 (s, 1H), 6.83–6.95 (m,3H), 7.21 (d, J ¼ 3.0 Hz, 1H),
7.26–7.39 (m, 3H), 7.62 (s, 1H); 13C NMR (CDCl3/TMS, 75.3
MHz): 35.9, 51.8, 54.2, 75.9, 110.1, 122.8, 128.0, 128.3,
128.6, 128.9, 129.2, 129.7, 130.0, 134.3, 138.5, 139.0, 142.5,
143.2, 164.7, 175.7. MS (EI) m/z 423 (Mþ).
[3] Genin, M. J.; Allwine, D. A.; Anderson, D. J.; Babbachyn,
M. R.; Emmert, D. E.; Garmon, S. A.; Graber, D. A.; Grega, K. C.;
Hester, J. B.; Hutchinson, D. K.; Morris, J.; Reischer, R. J.; Ford, C.
W.; Zurenko, G. E.; Hamel, J. C.; Schaadt, R. D.; Stapert, D.; Yagi,
B. H. J Med Chem 2000, 43, 953.
Ethyl 2-(1-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-5-fluoro-
3-hydroxy-2-oxoindolin-3-yl)acrylate (4k). White solid: Rf
(60% EA/hexane) 0.31; IR (KBr): 3371, 1718, 1630, 1469,
1
1318, 1183 cmꢂ1; H NMR (CDCl3/TMS, 300.1 MHz): d 1.07
[4] Alvarez, R.; Valazquez, S.; San, F.; Aquaro, S.; De, C.;
Perno, C. F.; Karlsson, F. A.; Balzarini, J.; Camarasa, M. J. J Med
Chem 1994, 37, 4185.
(t, 3H, J ¼ 7.1 Hz), 2.48 (brs, 1H), 3.92 (q, J ¼ 4.3, 11.2 Hz,
2H), 4.85(d, J ¼ 15.9 Hz, 1H), 5.04 (d, J ¼ 15.9 Hz, 1H),
5.39 (AB quartet, J ¼ 9.3 Hz, 2H), 6.44 (s, 1H), 6.50 (s, 1H),
6.82–6.92 (m, 5H), 7.28–7.34 (m, 3H), 7.64 (s, 1H); 13C NMR
(CDCl3/TMS, 75.3 MHz): 14.2, 22.4, 33.8, 51.8, 53.9, 62.0,
75.5, 96.0, 99.2, 109.6, 113.8, 113.9, 115.4, 122.4, 128.3,
128.6, 128.8, 129.0, 129.4, 134.2, 138.4, 142.0, 164.1, 172.0.
MS (EI) m/z 437 (Mþ).
2-(1-(((1-benzyl-1H-1,2,3-triazol-4-l)methoxy)methyl)-3-
hydroxy-2-oxoindolin-3-yl) acrylonitrile (6a). White solid: Rf
(60% EA/hexane) 0.29; IR (KBr): 3377, 1615, 1473, 1117
cmꢂ1 1H NMR (CDCl3/TMS, 300.1 MHz): d 3.43 (s, 1H,
;
[5] (a) Brockunier, L. L.; Parmee, E. R.; Ok, H. O.; Candelore,
M. R.; Cascieri, M. A.; Colwell, L. F.; Deng, L.; Feeney, W. P.; Forr-
est, M. J.; Hom, G. J.; Maclntyre, D. E.; Tota, L.; Wyvratt, M. J.;
Fisher, M. H.; Weber, A. E. Bioorg Med Chem Lett 2000, 10, 2111;
(b) Trybulski, E. J.; Benjamin, L.; Vitone, S.; Walser, A.; Fryer, I. R.
J Med Chem 1983, 26, 367.
[6] Chandrasekhar, S.; Prakash, S. J.; Jagadeshwar, V.; Narsih-
mulu, Ch. Tetrahedron Lett 2000, 42, 5561.
[7] Chandrasekhar, S.; Narsihmulu, Ch.; Jagadeshwar, V. Syn-
lett 2001, 5, 771.
[8] Rostovstev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless,
K. B. Angew Chem Int Ed Engl 2002, 41, 2596.
brs), 3.51 (s, 3H), 3.94–5.49 (m, 6H), 6.45 (s, 1H), 6.49 (s,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet